Find out more about the latest RNA drug development
22.08.2023 Munich’s leading researchers have preclinically evaluated an active RNA Drug called RCS-21 to prevent severe pneumonia and fibrosis, caused by infections such as SARS-CoV2
Neuried, Munich Mai 25, 2023 baseclick indicates new dimensions to approach nucleic acid-based therapies, in association with the Cluster for Nucleic Acid Therapeutics Munich (CNATM)